Cargando…
In silico clinical trials for anti-aging therapies
Therapeutic strategies targeting the hallmarks of aging can be broadly grouped into four categories, namely systemic (blood) factors, metabolic manipulation (diet regimens and dietary restriction mimetics), suppression of cellular senescence (senolytics), and cellular reprogramming, which likely hav...
Autores principales: | Menendez, Javier A., Cuyàs, Elisabet, Folguera-Blasco, Núria, Verdura, Sara, Martin-Castillo, Begoña, Joven, Jorge, Alarcón, Tomás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738435/ https://www.ncbi.nlm.nih.gov/pubmed/31444969 http://dx.doi.org/10.18632/aging.102180 |
Ejemplares similares
-
Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome
por: Menendez, Javier A., et al.
Publicado: (2016) -
Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model
por: Folguera-Blasco, Núria, et al.
Publicado: (2018) -
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
por: Cuyàs, Elisabet, et al.
Publicado: (2020) -
Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity
por: Cuyàs, Elisabet, et al.
Publicado: (2017) -
Circulating levels of MOTS-c in patients with breast cancer treated with metformin
por: Cuyàs, Elisabet, et al.
Publicado: (2022)